Correlation between copy number variation genes (focal events) and selected clinical features
Uterine Corpus Endometrioid Carcinoma (Primary solid tumor)
17 October 2014  |  analyses__2014_10_17
Maintainer Information
Citation Information
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2014): Correlation between copy number variation genes (focal events) and selected clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C10R9NBD
Overview
Introduction

This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.

Summary

Testing the association between copy number variation 100 focal events and 7 clinical features across 505 patients, 161 significant findings detected with Q value < 0.25.

  • amp_1p35.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_1p34.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_1p22.3 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_1q21.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_1q22 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_2p24.3 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_2q13 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_3p25.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_3p14.1 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_3q26.2 cnv correlated to 'AGE',  'HISTOLOGICAL.TYPE', and 'RACE'.

  • amp_3q26.2 cnv correlated to 'AGE',  'HISTOLOGICAL.TYPE', and 'RACE'.

  • amp_4p16.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_5p15.33 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_5q35.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_6p24.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_6p22.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_6q25.1 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_7q31.2 cnv correlated to 'Time to Death'.

  • amp_8p11.21 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.

  • amp_8q24.21 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.

  • amp_8q24.21 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_9p24.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_9q34.3 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_11p11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_11q13.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_11q14.1 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.

  • amp_12p12.1 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_12q13.11 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_12q13.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_13q34 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_14q24.3 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_14q32.33 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_15q26.3 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_16p11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_17q11.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_17q12 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_17q25.1 cnv correlated to 'HISTOLOGICAL.TYPE' and 'RACE'.

  • amp_18p11.31 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_18q11.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • amp_19p13.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_19q12 cnv correlated to 'Time to Death',  'AGE',  'HISTOLOGICAL.TYPE', and 'RACE'.

  • amp_20p13 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_20q11.21 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_20q13.12 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_20q13.33 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • amp_22q12.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_1p36.21 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_1p36.11 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_2q22.1 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.

  • del_2q37.3 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_3p14.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_3q13.31 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_4p16.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_4p15.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_4q22.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_4q34.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_5q12.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_6q26 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_7p22.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_7q11.22 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_7q31.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_7q36.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_8p23.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_8p21.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_9p23 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_9q21.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_9q34.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_10q23.31 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_11p15.5 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_11q14.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_11q25 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_12q23.1 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_12q24.33 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_13q11 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_13q14.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_14q13.1 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_15q15.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_15q23 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_16p13.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_16q21 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_16q22.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_16q23.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_17p13.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_17p11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_17q11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_17q21.31 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_18q21.2 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_18q23 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_19p13.3 cnv correlated to 'Time to Death',  'AGE', and 'HISTOLOGICAL.TYPE'.

  • del_19p12 cnv correlated to 'HISTOLOGICAL.TYPE'.

  • del_19q13.43 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.

  • del_20p12.1 cnv correlated to 'Time to Death'.

  • del_22q13.32 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.

  • del_xp21.1 cnv correlated to 'Time to Death',  'AGE', and 'HISTOLOGICAL.TYPE'.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between significant copy number variation of 100 focal events and 7 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 161 significant findings detected.

Clinical
Features
Time
to
Death
AGE HISTOLOGICAL
TYPE
RADIATIONS
RADIATION
REGIMENINDICATION
COMPLETENESS
OF
RESECTION
RACE ETHNICITY
nCNV (%) nWild-Type logrank test Wilcoxon-test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test
amp 19q12 106 (21%) 399 0.00023
(0.127)
3e-08
(2.07e-05)
1e-05
(0.00672)
0.391
(1.00)
0.235
(1.00)
1e-05
(0.00672)
0.736
(1.00)
amp 3q26 2 158 (31%) 347 0.00607
(1.00)
3.02e-10
(2.11e-07)
1e-05
(0.00672)
0.0853
(1.00)
0.223
(1.00)
0.00012
(0.0678)
0.762
(1.00)
amp 3q26 2 148 (29%) 357 0.00538
(1.00)
2.42e-08
(1.68e-05)
1e-05
(0.00672)
0.124
(1.00)
0.147
(1.00)
0.00036
(0.195)
0.361
(1.00)
del 19p13 3 141 (28%) 364 1.45e-05
(0.00845)
2.02e-10
(1.42e-07)
1e-05
(0.00672)
0.0965
(1.00)
0.00465
(1.00)
0.00055
(0.295)
0.204
(1.00)
del xp21 1 77 (15%) 428 0.000365
(0.198)
0.000263
(0.145)
1e-05
(0.00672)
0.331
(1.00)
0.12
(1.00)
0.00462
(1.00)
0.118
(1.00)
amp 1p35 2 50 (10%) 455 0.13
(1.00)
0.000249
(0.138)
1e-05
(0.00672)
0.621
(1.00)
0.496
(1.00)
0.16
(1.00)
0.334
(1.00)
amp 1p34 2 65 (13%) 440 0.0264
(1.00)
0.000171
(0.0955)
1e-05
(0.00672)
0.299
(1.00)
0.0431
(1.00)
0.0458
(1.00)
0.663
(1.00)
amp 1q21 3 225 (45%) 280 0.0239
(1.00)
5.29e-05
(0.0302)
1e-05
(0.00672)
0.422
(1.00)
0.697
(1.00)
0.0106
(1.00)
0.398
(1.00)
amp 1q22 239 (47%) 266 0.00237
(1.00)
6.86e-07
(0.000467)
1e-05
(0.00672)
0.424
(1.00)
0.291
(1.00)
0.0257
(1.00)
0.577
(1.00)
amp 2q13 109 (22%) 396 0.00151
(0.77)
0.000358
(0.195)
1e-05
(0.00672)
0.397
(1.00)
0.206
(1.00)
0.186
(1.00)
1
(1.00)
amp 3p25 1 78 (15%) 427 0.0443
(1.00)
0.000359
(0.195)
1e-05
(0.00672)
0.0524
(1.00)
0.781
(1.00)
0.00342
(1.00)
0.438
(1.00)
amp 4p16 3 51 (10%) 454 0.329
(1.00)
1.15e-05
(0.00673)
1e-05
(0.00672)
0.741
(1.00)
0.231
(1.00)
0.355
(1.00)
0.334
(1.00)
amp 5p15 33 83 (16%) 422 0.0026
(1.00)
9.85e-05
(0.056)
1e-05
(0.00672)
0.14
(1.00)
0.156
(1.00)
0.00325
(1.00)
0.246
(1.00)
amp 5q35 3 50 (10%) 455 0.0929
(1.00)
0.00021
(0.116)
1e-05
(0.00672)
0.134
(1.00)
0.465
(1.00)
0.0241
(1.00)
0.377
(1.00)
amp 6p24 2 109 (22%) 396 0.31
(1.00)
2.24e-06
(0.00152)
1e-05
(0.00672)
0.0685
(1.00)
0.74
(1.00)
0.188
(1.00)
1
(1.00)
amp 6p22 3 98 (19%) 407 0.971
(1.00)
0.000166
(0.0927)
1e-05
(0.00672)
0.101
(1.00)
0.491
(1.00)
0.0151
(1.00)
0.477
(1.00)
amp 8p11 21 153 (30%) 352 6.02e-05
(0.0343)
0.843
(1.00)
1e-05
(0.00672)
0.0223
(1.00)
0.00744
(1.00)
0.256
(1.00)
0.762
(1.00)
amp 8q24 21 194 (38%) 311 0.000424
(0.229)
0.057
(1.00)
1e-05
(0.00672)
0.00768
(1.00)
0.21
(1.00)
0.143
(1.00)
0.577
(1.00)
amp 11p11 2 48 (10%) 457 0.0153
(1.00)
0.000132
(0.0744)
1e-05
(0.00672)
0.865
(1.00)
0.428
(1.00)
0.322
(1.00)
0.32
(1.00)
amp 11q14 1 54 (11%) 451 0.000188
(0.105)
0.0165
(1.00)
1e-05
(0.00672)
0.147
(1.00)
0.284
(1.00)
0.144
(1.00)
1
(1.00)
amp 13q34 56 (11%) 449 0.396
(1.00)
5.36e-05
(0.0306)
1e-05
(0.00672)
1
(1.00)
0.0158
(1.00)
0.0191
(1.00)
1
(1.00)
amp 16p11 2 62 (12%) 443 0.00287
(1.00)
0.000351
(0.192)
1e-05
(0.00672)
0.447
(1.00)
0.0968
(1.00)
0.129
(1.00)
0.674
(1.00)
amp 17q25 1 94 (19%) 411 0.00487
(1.00)
0.00106
(0.557)
1e-05
(0.00672)
0.524
(1.00)
0.196
(1.00)
0.0001
(0.0566)
0.476
(1.00)
amp 18p11 31 89 (18%) 416 0.0675
(1.00)
0.000121
(0.0684)
1e-05
(0.00672)
0.0178
(1.00)
0.019
(1.00)
0.00156
(0.794)
1
(1.00)
amp 19p13 2 90 (18%) 415 0.0107
(1.00)
4.21e-10
(2.94e-07)
1e-05
(0.00672)
0.0507
(1.00)
0.242
(1.00)
0.0011
(0.575)
1
(1.00)
amp 20p13 110 (22%) 395 0.455
(1.00)
5.13e-06
(0.00346)
1e-05
(0.00672)
0.0296
(1.00)
0.536
(1.00)
0.0362
(1.00)
0.482
(1.00)
amp 20q11 21 140 (28%) 365 0.00209
(1.00)
7.39e-08
(5.06e-05)
1e-05
(0.00672)
0.0139
(1.00)
0.119
(1.00)
0.00982
(1.00)
0.341
(1.00)
amp 20q13 12 140 (28%) 365 0.018
(1.00)
3.13e-08
(2.16e-05)
1e-05
(0.00672)
0.00123
(0.636)
0.0583
(1.00)
0.00768
(1.00)
0.357
(1.00)
amp 20q13 33 138 (27%) 367 0.00992
(1.00)
4.38e-08
(3.01e-05)
1e-05
(0.00672)
0.00237
(1.00)
0.0173
(1.00)
0.0784
(1.00)
0.756
(1.00)
del 1p36 21 64 (13%) 441 0.618
(1.00)
9.94e-05
(0.0563)
1e-05
(0.00672)
0.881
(1.00)
0.419
(1.00)
0.108
(1.00)
0.19
(1.00)
del 1p36 11 74 (15%) 431 0.0586
(1.00)
4.73e-05
(0.0271)
1e-05
(0.00672)
0.575
(1.00)
0.0233
(1.00)
0.219
(1.00)
0.111
(1.00)
del 2q22 1 44 (9%) 461 3.43e-09
(2.39e-06)
0.00472
(1.00)
1e-05
(0.00672)
0.004
(1.00)
0.00299
(1.00)
0.0635
(1.00)
1
(1.00)
del 4p16 3 81 (16%) 424 0.0064
(1.00)
0.000385
(0.208)
1e-05
(0.00672)
0.418
(1.00)
0.784
(1.00)
0.328
(1.00)
0.708
(1.00)
del 4p15 2 83 (16%) 422 0.0072
(1.00)
0.000164
(0.0917)
1e-05
(0.00672)
0.227
(1.00)
0.362
(1.00)
0.39
(1.00)
0.253
(1.00)
del 4q22 1 94 (19%) 411 0.00456
(1.00)
4.13e-06
(0.0028)
1e-05
(0.00672)
0.25
(1.00)
0.0495
(1.00)
0.145
(1.00)
0.712
(1.00)
del 4q34 3 120 (24%) 385 0.0286
(1.00)
5.71e-07
(0.00039)
1e-05
(0.00672)
0.197
(1.00)
0.132
(1.00)
0.00636
(1.00)
1
(1.00)
del 5q12 1 101 (20%) 404 0.0373
(1.00)
1.22e-05
(0.00709)
1e-05
(0.00672)
0.454
(1.00)
0.644
(1.00)
0.0626
(1.00)
0.154
(1.00)
del 7p22 3 67 (13%) 438 0.0023
(1.00)
0.000132
(0.0743)
1e-05
(0.00672)
0.24
(1.00)
0.303
(1.00)
0.0777
(1.00)
0.674
(1.00)
del 7q11 22 39 (8%) 466 0.787
(1.00)
3.18e-05
(0.0184)
1e-05
(0.00672)
0.357
(1.00)
0.632
(1.00)
0.361
(1.00)
1
(1.00)
del 7q31 1 52 (10%) 453 0.0599
(1.00)
4.75e-05
(0.0272)
1e-05
(0.00672)
0.745
(1.00)
0.497
(1.00)
0.109
(1.00)
1
(1.00)
del 7q36 1 61 (12%) 444 0.0112
(1.00)
2.17e-07
(0.000148)
1e-05
(0.00672)
0.88
(1.00)
0.298
(1.00)
0.211
(1.00)
1
(1.00)
del 8p23 2 106 (21%) 399 0.00309
(1.00)
3.52e-05
(0.0203)
1e-05
(0.00672)
0.27
(1.00)
0.0329
(1.00)
0.00915
(1.00)
0.316
(1.00)
del 8p21 2 104 (21%) 401 0.0144
(1.00)
4.25e-06
(0.00287)
1e-05
(0.00672)
0.324
(1.00)
0.104
(1.00)
0.0124
(1.00)
1
(1.00)
del 9q21 2 117 (23%) 388 0.00121
(0.627)
5.62e-10
(3.92e-07)
1e-05
(0.00672)
0.287
(1.00)
0.175
(1.00)
0.0629
(1.00)
0.504
(1.00)
del 9q34 2 119 (24%) 386 0.00716
(1.00)
3.56e-08
(2.45e-05)
1e-05
(0.00672)
0.158
(1.00)
0.14
(1.00)
0.148
(1.00)
1
(1.00)
del 11p15 5 94 (19%) 411 0.0184
(1.00)
9.43e-06
(0.00634)
1e-05
(0.00672)
0.0144
(1.00)
0.0924
(1.00)
0.0896
(1.00)
0.292
(1.00)
del 11q14 1 64 (13%) 441 0.0318
(1.00)
0.000357
(0.195)
1e-05
(0.00672)
0.132
(1.00)
0.553
(1.00)
0.0549
(1.00)
0.026
(1.00)
del 11q25 86 (17%) 419 0.00556
(1.00)
0.000283
(0.156)
1e-05
(0.00672)
0.00506
(1.00)
0.321
(1.00)
0.058
(1.00)
0.708
(1.00)
del 12q24 33 56 (11%) 449 0.0416
(1.00)
3.82e-05
(0.022)
1e-05
(0.00672)
0.0554
(1.00)
0.0395
(1.00)
0.386
(1.00)
1
(1.00)
del 15q15 1 128 (25%) 377 0.00159
(0.81)
4.08e-08
(2.81e-05)
1e-05
(0.00672)
0.0116
(1.00)
0.0372
(1.00)
0.0451
(1.00)
1
(1.00)
del 15q23 107 (21%) 398 0.0341
(1.00)
1.23e-05
(0.00713)
1e-05
(0.00672)
0.0873
(1.00)
0.377
(1.00)
0.0368
(1.00)
0.315
(1.00)
del 16p13 3 83 (16%) 422 0.0263
(1.00)
1.33e-06
(0.000904)
1e-05
(0.00672)
0.14
(1.00)
0.106
(1.00)
0.0256
(1.00)
1
(1.00)
del 16q21 141 (28%) 364 0.0308
(1.00)
2.59e-08
(1.79e-05)
1e-05
(0.00672)
0.181
(1.00)
0.214
(1.00)
0.0236
(1.00)
1
(1.00)
del 16q22 3 144 (29%) 361 0.0891
(1.00)
1.78e-08
(1.23e-05)
1e-05
(0.00672)
0.269
(1.00)
0.182
(1.00)
0.0339
(1.00)
1
(1.00)
del 16q23 1 152 (30%) 353 0.00932
(1.00)
2.47e-08
(1.71e-05)
1e-05
(0.00672)
0.276
(1.00)
0.0157
(1.00)
0.00261
(1.00)
1
(1.00)
del 17p13 3 110 (22%) 395 0.0015
(0.769)
0.000294
(0.161)
1e-05
(0.00672)
0.0917
(1.00)
0.156
(1.00)
0.00453
(1.00)
1
(1.00)
del 17p11 2 115 (23%) 390 0.00153
(0.778)
5.37e-06
(0.00362)
1e-05
(0.00672)
0.153
(1.00)
0.515
(1.00)
0.0328
(1.00)
1
(1.00)
del 17q11 2 95 (19%) 410 0.0676
(1.00)
1.13e-06
(0.000771)
1e-05
(0.00672)
0.159
(1.00)
0.201
(1.00)
0.791
(1.00)
0.717
(1.00)
del 17q21 31 100 (20%) 405 0.00166
(0.84)
1.77e-05
(0.0103)
1e-05
(0.00672)
0.133
(1.00)
0.0353
(1.00)
0.222
(1.00)
0.0248
(1.00)
del 19q13 43 58 (11%) 447 0.00029
(0.16)
0.000967
(0.508)
1e-05
(0.00672)
0.64
(1.00)
0.0345
(1.00)
0.367
(1.00)
0.154
(1.00)
del 22q13 32 129 (26%) 376 0.00552
(1.00)
4.3e-08
(2.95e-05)
1e-05
(0.00672)
0.0218
(1.00)
0.308
(1.00)
0.0131
(1.00)
0.121
(1.00)
amp 1p22 3 90 (18%) 415 0.466
(1.00)
0.00188
(0.942)
0.00033
(0.181)
0.602
(1.00)
0.908
(1.00)
0.434
(1.00)
0.138
(1.00)
amp 2p24 3 112 (22%) 393 0.000688
(0.368)
0.0192
(1.00)
1e-05
(0.00672)
0.0412
(1.00)
0.823
(1.00)
0.446
(1.00)
0.314
(1.00)
amp 3p14 1 60 (12%) 445 0.000777
(0.412)
0.0103
(1.00)
4e-05
(0.023)
0.021
(1.00)
0.263
(1.00)
0.0155
(1.00)
0.0551
(1.00)
amp 6q25 1 80 (16%) 425 0.358
(1.00)
0.00353
(1.00)
1e-05
(0.00672)
0.339
(1.00)
0.297
(1.00)
0.00789
(1.00)
0.701
(1.00)
amp 7q31 2 82 (16%) 423 5.15e-07
(0.000352)
0.118
(1.00)
0.00184
(0.922)
0.0218
(1.00)
0.377
(1.00)
0.791
(1.00)
0.479
(1.00)
amp 8q24 21 200 (40%) 305 0.000789
(0.417)
0.0205
(1.00)
1e-05
(0.00672)
0.0058
(1.00)
0.0118
(1.00)
0.549
(1.00)
1
(1.00)
amp 9p24 2 61 (12%) 444 0.0223
(1.00)
0.00166
(0.84)
1e-05
(0.00672)
0.17
(1.00)
0.342
(1.00)
0.103
(1.00)
0.0141
(1.00)
amp 9q34 3 37 (7%) 468 0.0146
(1.00)
0.00163
(0.824)
1e-05
(0.00672)
1
(1.00)
0.269
(1.00)
0.00909
(1.00)
1
(1.00)
amp 11q13 2 67 (13%) 438 0.0494
(1.00)
0.000902
(0.475)
1e-05
(0.00672)
0.558
(1.00)
0.222
(1.00)
0.744
(1.00)
1
(1.00)
amp 12p12 1 86 (17%) 419 0.697
(1.00)
0.104
(1.00)
1e-05
(0.00672)
0.426
(1.00)
0.618
(1.00)
0.0978
(1.00)
0.136
(1.00)
amp 12q13 11 81 (16%) 424 0.503
(1.00)
0.639
(1.00)
1e-05
(0.00672)
0.104
(1.00)
0.392
(1.00)
0.00821
(1.00)
0.703
(1.00)
amp 12q13 2 92 (18%) 413 0.541
(1.00)
0.0859
(1.00)
1e-05
(0.00672)
0.0384
(1.00)
0.0836
(1.00)
0.0738
(1.00)
1
(1.00)
amp 14q24 3 59 (12%) 446 0.000753
(0.4)
0.00133
(0.685)
1e-05
(0.00672)
0.122
(1.00)
0.365
(1.00)
0.491
(1.00)
0.653
(1.00)
amp 14q32 33 72 (14%) 433 0.076
(1.00)
0.000505
(0.272)
1e-05
(0.00672)
0.0146
(1.00)
0.211
(1.00)
0.0091
(1.00)
0.702
(1.00)
amp 15q26 3 36 (7%) 469 0.0383
(1.00)
0.00511
(1.00)
0.00015
(0.084)
0.0791
(1.00)
0.0101
(1.00)
0.796
(1.00)
0.32
(1.00)
amp 17q11 2 68 (13%) 437 0.0288
(1.00)
0.00583
(1.00)
1e-05
(0.00672)
0.38
(1.00)
0.00125
(0.646)
0.00544
(1.00)
0.22
(1.00)
amp 17q12 69 (14%) 436 0.00232
(1.00)
0.00128
(0.661)
1e-05
(0.00672)
1
(1.00)
0.173
(1.00)
0.00805
(1.00)
1
(1.00)
amp 18q11 2 64 (13%) 441 0.0337
(1.00)
0.00177
(0.891)
1e-05
(0.00672)
0.368
(1.00)
0.0296
(1.00)
0.00427
(1.00)
1
(1.00)
amp 22q12 2 58 (11%) 447 0.00178
(0.895)
0.000742
(0.395)
1e-05
(0.00672)
0.0841
(1.00)
0.00092
(0.484)
0.0118
(1.00)
0.653
(1.00)
del 2q37 3 49 (10%) 456 0.0648
(1.00)
0.00327
(1.00)
0.00014
(0.0785)
0.177
(1.00)
0.063
(1.00)
0.116
(1.00)
1
(1.00)
del 3p14 2 69 (14%) 436 0.149
(1.00)
0.00071
(0.379)
1e-05
(0.00672)
0.469
(1.00)
0.72
(1.00)
0.0471
(1.00)
0.229
(1.00)
del 3q13 31 40 (8%) 465 0.37
(1.00)
0.000718
(0.383)
2e-05
(0.0116)
0.356
(1.00)
0.855
(1.00)
0.805
(1.00)
0.611
(1.00)
del 6q26 43 (9%) 462 0.25
(1.00)
0.00543
(1.00)
1e-05
(0.00672)
0.596
(1.00)
0.949
(1.00)
0.806
(1.00)
0.611
(1.00)
del 9p23 70 (14%) 435 0.179
(1.00)
0.00272
(1.00)
1e-05
(0.00672)
0.0837
(1.00)
0.25
(1.00)
0.173
(1.00)
1
(1.00)
del 10q23 31 68 (13%) 437 0.0856
(1.00)
0.000608
(0.326)
1e-05
(0.00672)
0.0124
(1.00)
0.111
(1.00)
0.306
(1.00)
0.685
(1.00)
del 12q23 1 46 (9%) 459 0.0129
(1.00)
0.0024
(1.00)
1e-05
(0.00672)
0.122
(1.00)
0.0229
(1.00)
0.0344
(1.00)
1
(1.00)
del 13q11 86 (17%) 419 0.014
(1.00)
0.00124
(0.642)
1e-05
(0.00672)
0.11
(1.00)
0.161
(1.00)
0.184
(1.00)
0.257
(1.00)
del 13q14 2 93 (18%) 412 0.0244
(1.00)
0.00193
(0.964)
1e-05
(0.00672)
0.0146
(1.00)
0.44
(1.00)
0.142
(1.00)
0.151
(1.00)
del 14q13 1 67 (13%) 438 0.0122
(1.00)
0.00407
(1.00)
1e-05
(0.00672)
0.379
(1.00)
0.966
(1.00)
0.00683
(1.00)
0.22
(1.00)
del 18q21 2 82 (16%) 423 0.654
(1.00)
0.000777
(0.412)
1e-05
(0.00672)
0.0101
(1.00)
0.141
(1.00)
0.048
(1.00)
0.253
(1.00)
del 18q23 87 (17%) 418 0.00809
(1.00)
0.00113
(0.589)
1e-05
(0.00672)
0.00143
(0.735)
0.00978
(1.00)
0.0698
(1.00)
0.0596
(1.00)
del 19p12 52 (10%) 453 0.0238
(1.00)
0.0203
(1.00)
1e-05
(0.00672)
0.048
(1.00)
0.119
(1.00)
0.0679
(1.00)
0.635
(1.00)
del 20p12 1 31 (6%) 474 1.98e-05
(0.0115)
0.226
(1.00)
0.00047
(0.253)
0.836
(1.00)
0.0491
(1.00)
0.263
(1.00)
0.237
(1.00)
amp 1q44 202 (40%) 303 0.148
(1.00)
0.00342
(1.00)
0.623
(1.00)
0.839
(1.00)
0.571
(1.00)
0.354
(1.00)
0.255
(1.00)
amp 8p11 22 120 (24%) 385 0.0216
(1.00)
0.144
(1.00)
0.843
(1.00)
0.292
(1.00)
0.706
(1.00)
0.367
(1.00)
0.529
(1.00)
amp 10q22 2 136 (27%) 369 0.329
(1.00)
0.361
(1.00)
0.00179
(0.899)
0.501
(1.00)
0.583
(1.00)
0.558
(1.00)
1
(1.00)
amp xp11 23 82 (16%) 423 0.198
(1.00)
0.131
(1.00)
0.00119
(0.62)
0.0573
(1.00)
0.542
(1.00)
0.983
(1.00)
0.704
(1.00)
amp xq28 83 (16%) 422 0.00132
(0.681)
0.129
(1.00)
0.00281
(1.00)
0.894
(1.00)
0.209
(1.00)
0.569
(1.00)
0.445
(1.00)
del 2p25 3 25 (5%) 480 0.0387
(1.00)
0.0456
(1.00)
0.00615
(1.00)
0.105
(1.00)
0.286
(1.00)
0.337
(1.00)
1
(1.00)
'amp_1p35.2' versus 'AGE'

P value = 0.000249 (Wilcoxon-test), Q value = 0.14

Table S1.  Gene #1: 'amp_1p35.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 1(1P35.2) MUTATED 50 68.6 (9.0)
AMP PEAK 1(1P35.2) WILD-TYPE 454 63.3 (11.3)

Figure S1.  Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #2: 'AGE'

'amp_1p35.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S2.  Gene #1: 'amp_1p35.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 1(1P35.2) MUTATED 14 5 31
AMP PEAK 1(1P35.2) WILD-TYPE 366 16 73

Figure S2.  Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_1p34.2' versus 'AGE'

P value = 0.000171 (Wilcoxon-test), Q value = 0.095

Table S3.  Gene #2: 'amp_1p34.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 2(1P34.2) MUTATED 65 68.5 (9.7)
AMP PEAK 2(1P34.2) WILD-TYPE 439 63.2 (11.3)

Figure S3.  Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #2: 'AGE'

'amp_1p34.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S4.  Gene #2: 'amp_1p34.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 2(1P34.2) MUTATED 19 7 39
AMP PEAK 2(1P34.2) WILD-TYPE 361 14 65

Figure S4.  Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_1p22.3' versus 'HISTOLOGICAL.TYPE'

P value = 0.00033 (Fisher's exact test), Q value = 0.18

Table S5.  Gene #3: 'amp_1p22.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 3(1P22.3) MUTATED 53 5 32
AMP PEAK 3(1P22.3) WILD-TYPE 327 16 72

Figure S5.  Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_1q21.3' versus 'AGE'

P value = 5.29e-05 (Wilcoxon-test), Q value = 0.03

Table S6.  Gene #4: 'amp_1q21.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 4(1Q21.3) MUTATED 225 66.2 (10.3)
AMP PEAK 4(1Q21.3) WILD-TYPE 279 61.9 (11.6)

Figure S6.  Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #2: 'AGE'

'amp_1q21.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S7.  Gene #4: 'amp_1q21.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 4(1Q21.3) MUTATED 148 10 67
AMP PEAK 4(1Q21.3) WILD-TYPE 232 11 37

Figure S7.  Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_1q22' versus 'AGE'

P value = 6.86e-07 (Wilcoxon-test), Q value = 0.00047

Table S8.  Gene #5: 'amp_1q22' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 5(1Q22) MUTATED 239 66.5 (10.4)
AMP PEAK 5(1Q22) WILD-TYPE 265 61.4 (11.4)

Figure S8.  Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #2: 'AGE'

'amp_1q22' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S9.  Gene #5: 'amp_1q22' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 5(1Q22) MUTATED 155 10 74
AMP PEAK 5(1Q22) WILD-TYPE 225 11 30

Figure S9.  Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_2p24.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S10.  Gene #7: 'amp_2p24.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 7(2P24.3) MUTATED 53 7 52
AMP PEAK 7(2P24.3) WILD-TYPE 327 14 52

Figure S10.  Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_2q13' versus 'AGE'

P value = 0.000358 (Wilcoxon-test), Q value = 0.19

Table S11.  Gene #8: 'amp_2q13' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 8(2Q13) MUTATED 108 66.9 (9.1)
AMP PEAK 8(2Q13) WILD-TYPE 396 63.0 (11.6)

Figure S11.  Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #2: 'AGE'

'amp_2q13' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S12.  Gene #8: 'amp_2q13' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 8(2Q13) MUTATED 43 5 61
AMP PEAK 8(2Q13) WILD-TYPE 337 16 43

Figure S12.  Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_3p25.1' versus 'AGE'

P value = 0.000359 (Wilcoxon-test), Q value = 0.2

Table S13.  Gene #9: 'amp_3p25.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 9(3P25.1) MUTATED 78 68.3 (10.5)
AMP PEAK 9(3P25.1) WILD-TYPE 426 63.0 (11.2)

Figure S13.  Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #2: 'AGE'

'amp_3p25.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S14.  Gene #9: 'amp_3p25.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 9(3P25.1) MUTATED 34 1 43
AMP PEAK 9(3P25.1) WILD-TYPE 346 20 61

Figure S14.  Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_3p14.1' versus 'HISTOLOGICAL.TYPE'

P value = 4e-05 (Fisher's exact test), Q value = 0.023

Table S15.  Gene #10: 'amp_3p14.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 10(3P14.1) MUTATED 31 3 26
AMP PEAK 10(3P14.1) WILD-TYPE 349 18 78

Figure S15.  Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_3q26.2' versus 'AGE'

P value = 3.02e-10 (Wilcoxon-test), Q value = 2.1e-07

Table S16.  Gene #11: 'amp_3q26.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 11(3Q26.2) MUTATED 158 68.2 (9.4)
AMP PEAK 11(3Q26.2) WILD-TYPE 346 61.9 (11.4)

Figure S16.  Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #2: 'AGE'

'amp_3q26.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S17.  Gene #11: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 11(3Q26.2) MUTATED 68 8 82
AMP PEAK 11(3Q26.2) WILD-TYPE 312 13 22

Figure S17.  Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_3q26.2' versus 'RACE'

P value = 0.00012 (Fisher's exact test), Q value = 0.068

Table S18.  Gene #11: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 19 90 9 357
AMP PEAK 11(3Q26.2) MUTATED 0 3 45 4 95
AMP PEAK 11(3Q26.2) WILD-TYPE 4 16 45 5 262

Figure S18.  Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

'amp_3q26.2' versus 'AGE'

P value = 2.42e-08 (Wilcoxon-test), Q value = 1.7e-05

Table S19.  Gene #12: 'amp_3q26.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 12(3Q26.2) MUTATED 148 67.9 (9.4)
AMP PEAK 12(3Q26.2) WILD-TYPE 356 62.1 (11.5)

Figure S19.  Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #2: 'AGE'

'amp_3q26.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S20.  Gene #12: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 12(3Q26.2) MUTATED 61 7 80
AMP PEAK 12(3Q26.2) WILD-TYPE 319 14 24

Figure S20.  Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_3q26.2' versus 'RACE'

P value = 0.00036 (Fisher's exact test), Q value = 0.2

Table S21.  Gene #12: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 19 90 9 357
AMP PEAK 12(3Q26.2) MUTATED 0 3 42 4 89
AMP PEAK 12(3Q26.2) WILD-TYPE 4 16 48 5 268

Figure S21.  Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

'amp_4p16.3' versus 'AGE'

P value = 1.15e-05 (Wilcoxon-test), Q value = 0.0067

Table S22.  Gene #13: 'amp_4p16.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 13(4P16.3) MUTATED 51 69.8 (9.0)
AMP PEAK 13(4P16.3) WILD-TYPE 453 63.2 (11.2)

Figure S22.  Get High-res Image Gene #13: 'amp_4p16.3' versus Clinical Feature #2: 'AGE'

'amp_4p16.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S23.  Gene #13: 'amp_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 13(4P16.3) MUTATED 15 1 35
AMP PEAK 13(4P16.3) WILD-TYPE 365 20 69

Figure S23.  Get High-res Image Gene #13: 'amp_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_5p15.33' versus 'AGE'

P value = 9.85e-05 (Wilcoxon-test), Q value = 0.056

Table S24.  Gene #14: 'amp_5p15.33' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 14(5P15.33) MUTATED 83 67.6 (10.1)
AMP PEAK 14(5P15.33) WILD-TYPE 421 63.1 (11.3)

Figure S24.  Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #2: 'AGE'

'amp_5p15.33' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S25.  Gene #14: 'amp_5p15.33' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 14(5P15.33) MUTATED 28 3 52
AMP PEAK 14(5P15.33) WILD-TYPE 352 18 52

Figure S25.  Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_5q35.3' versus 'AGE'

P value = 0.00021 (Wilcoxon-test), Q value = 0.12

Table S26.  Gene #15: 'amp_5q35.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 15(5Q35.3) MUTATED 50 69.3 (10.3)
AMP PEAK 15(5Q35.3) WILD-TYPE 454 63.2 (11.2)

Figure S26.  Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #2: 'AGE'

'amp_5q35.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S27.  Gene #15: 'amp_5q35.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 15(5Q35.3) MUTATED 19 2 29
AMP PEAK 15(5Q35.3) WILD-TYPE 361 19 75

Figure S27.  Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_6p24.2' versus 'AGE'

P value = 2.24e-06 (Wilcoxon-test), Q value = 0.0015

Table S28.  Gene #16: 'amp_6p24.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 16(6P24.2) MUTATED 109 68.0 (9.8)
AMP PEAK 16(6P24.2) WILD-TYPE 395 62.7 (11.3)

Figure S28.  Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #2: 'AGE'

'amp_6p24.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S29.  Gene #16: 'amp_6p24.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 16(6P24.2) MUTATED 42 5 62
AMP PEAK 16(6P24.2) WILD-TYPE 338 16 42

Figure S29.  Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_6p22.3' versus 'AGE'

P value = 0.000166 (Wilcoxon-test), Q value = 0.093

Table S30.  Gene #17: 'amp_6p22.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 17(6P22.3) MUTATED 98 67.3 (9.9)
AMP PEAK 17(6P22.3) WILD-TYPE 406 63.0 (11.4)

Figure S30.  Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #2: 'AGE'

'amp_6p22.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S31.  Gene #17: 'amp_6p22.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 17(6P22.3) MUTATED 37 4 57
AMP PEAK 17(6P22.3) WILD-TYPE 343 17 47

Figure S31.  Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_6q25.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S32.  Gene #18: 'amp_6q25.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 18(6Q25.1) MUTATED 42 2 36
AMP PEAK 18(6Q25.1) WILD-TYPE 338 19 68

Figure S32.  Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_7q31.2' versus 'Time to Death'

P value = 5.15e-07 (logrank test), Q value = 0.00035

Table S33.  Gene #19: 'amp_7q31.2' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
AMP PEAK 19(7Q31.2) MUTATED 81 21 0.0 - 125.4 (16.0)
AMP PEAK 19(7Q31.2) WILD-TYPE 422 39 0.1 - 191.8 (23.9)

Figure S33.  Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #1: 'Time to Death'

'amp_8p11.21' versus 'Time to Death'

P value = 6.02e-05 (logrank test), Q value = 0.034

Table S34.  Gene #21: 'amp_8p11.21' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
AMP PEAK 21(8P11.21) MUTATED 152 30 0.0 - 125.4 (19.3)
AMP PEAK 21(8P11.21) WILD-TYPE 351 30 0.1 - 191.8 (24.3)

Figure S34.  Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #1: 'Time to Death'

'amp_8p11.21' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S35.  Gene #21: 'amp_8p11.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 21(8P11.21) MUTATED 90 7 56
AMP PEAK 21(8P11.21) WILD-TYPE 290 14 48

Figure S35.  Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_8q24.21' versus 'Time to Death'

P value = 0.000424 (logrank test), Q value = 0.23

Table S36.  Gene #22: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
AMP PEAK 22(8Q24.21) MUTATED 193 34 0.0 - 191.8 (19.3)
AMP PEAK 22(8Q24.21) WILD-TYPE 310 26 0.1 - 185.8 (24.5)

Figure S36.  Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

'amp_8q24.21' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S37.  Gene #22: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 22(8Q24.21) MUTATED 109 10 75
AMP PEAK 22(8Q24.21) WILD-TYPE 271 11 29

Figure S37.  Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_8q24.21' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S38.  Gene #23: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 23(8Q24.21) MUTATED 112 9 79
AMP PEAK 23(8Q24.21) WILD-TYPE 268 12 25

Figure S38.  Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_9p24.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S39.  Gene #24: 'amp_9p24.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 24(9P24.2) MUTATED 23 3 35
AMP PEAK 24(9P24.2) WILD-TYPE 357 18 69

Figure S39.  Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_9q34.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S40.  Gene #25: 'amp_9q34.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 25(9Q34.3) MUTATED 12 4 21
AMP PEAK 25(9Q34.3) WILD-TYPE 368 17 83

Figure S40.  Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_11p11.2' versus 'AGE'

P value = 0.000132 (Wilcoxon-test), Q value = 0.074

Table S41.  Gene #27: 'amp_11p11.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 27(11P11.2) MUTATED 48 69.8 (9.6)
AMP PEAK 27(11P11.2) WILD-TYPE 456 63.2 (11.2)

Figure S41.  Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #2: 'AGE'

'amp_11p11.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S42.  Gene #27: 'amp_11p11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 27(11P11.2) MUTATED 16 4 28
AMP PEAK 27(11P11.2) WILD-TYPE 364 17 76

Figure S42.  Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_11q13.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S43.  Gene #28: 'amp_11q13.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 28(11Q13.2) MUTATED 31 3 33
AMP PEAK 28(11Q13.2) WILD-TYPE 349 18 71

Figure S43.  Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_11q14.1' versus 'Time to Death'

P value = 0.000188 (logrank test), Q value = 0.1

Table S44.  Gene #29: 'amp_11q14.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
AMP PEAK 29(11Q14.1) MUTATED 54 14 0.0 - 102.3 (19.3)
AMP PEAK 29(11Q14.1) WILD-TYPE 449 46 0.1 - 191.8 (23.3)

Figure S44.  Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #1: 'Time to Death'

'amp_11q14.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S45.  Gene #29: 'amp_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 29(11Q14.1) MUTATED 20 1 33
AMP PEAK 29(11Q14.1) WILD-TYPE 360 20 71

Figure S45.  Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_12p12.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S46.  Gene #30: 'amp_12p12.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 30(12P12.1) MUTATED 41 4 41
AMP PEAK 30(12P12.1) WILD-TYPE 339 17 63

Figure S46.  Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_12q13.11' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S47.  Gene #31: 'amp_12q13.11' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 31(12Q13.11) MUTATED 38 4 39
AMP PEAK 31(12Q13.11) WILD-TYPE 342 17 65

Figure S47.  Get High-res Image Gene #31: 'amp_12q13.11' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_12q13.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S48.  Gene #32: 'amp_12q13.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 32(12Q13.2) MUTATED 47 4 41
AMP PEAK 32(12Q13.2) WILD-TYPE 333 17 63

Figure S48.  Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_13q34' versus 'AGE'

P value = 5.36e-05 (Wilcoxon-test), Q value = 0.031

Table S49.  Gene #33: 'amp_13q34' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 33(13Q34) MUTATED 56 69.1 (7.5)
AMP PEAK 33(13Q34) WILD-TYPE 448 63.2 (11.4)

Figure S49.  Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #2: 'AGE'

'amp_13q34' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S50.  Gene #33: 'amp_13q34' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 33(13Q34) MUTATED 14 4 38
AMP PEAK 33(13Q34) WILD-TYPE 366 17 66

Figure S50.  Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_14q24.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S51.  Gene #34: 'amp_14q24.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 34(14Q24.3) MUTATED 20 4 35
AMP PEAK 34(14Q24.3) WILD-TYPE 360 17 69

Figure S51.  Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_14q32.33' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S52.  Gene #35: 'amp_14q32.33' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 35(14Q32.33) MUTATED 29 5 38
AMP PEAK 35(14Q32.33) WILD-TYPE 351 16 66

Figure S52.  Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_15q26.3' versus 'HISTOLOGICAL.TYPE'

P value = 0.00015 (Fisher's exact test), Q value = 0.084

Table S53.  Gene #36: 'amp_15q26.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 36(15Q26.3) MUTATED 17 1 18
AMP PEAK 36(15Q26.3) WILD-TYPE 363 20 86

Figure S53.  Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_16p11.2' versus 'AGE'

P value = 0.000351 (Wilcoxon-test), Q value = 0.19

Table S54.  Gene #37: 'amp_16p11.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 37(16P11.2) MUTATED 62 68.3 (9.0)
AMP PEAK 37(16P11.2) WILD-TYPE 442 63.2 (11.4)

Figure S54.  Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #2: 'AGE'

'amp_16p11.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S55.  Gene #37: 'amp_16p11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 37(16P11.2) MUTATED 20 2 40
AMP PEAK 37(16P11.2) WILD-TYPE 360 19 64

Figure S55.  Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_17q11.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S56.  Gene #38: 'amp_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 38(17Q11.2) MUTATED 16 6 46
AMP PEAK 38(17Q11.2) WILD-TYPE 364 15 58

Figure S56.  Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_17q12' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S57.  Gene #39: 'amp_17q12' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 39(17Q12) MUTATED 18 3 48
AMP PEAK 39(17Q12) WILD-TYPE 362 18 56

Figure S57.  Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_17q25.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S58.  Gene #40: 'amp_17q25.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 40(17Q25.1) MUTATED 34 9 51
AMP PEAK 40(17Q25.1) WILD-TYPE 346 12 53

Figure S58.  Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_17q25.1' versus 'RACE'

P value = 1e-04 (Fisher's exact test), Q value = 0.057

Table S59.  Gene #40: 'amp_17q25.1' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 19 90 9 357
AMP PEAK 40(17Q25.1) MUTATED 0 0 32 2 56
AMP PEAK 40(17Q25.1) WILD-TYPE 4 19 58 7 301

Figure S59.  Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #6: 'RACE'

'amp_18p11.31' versus 'AGE'

P value = 0.000121 (Wilcoxon-test), Q value = 0.068

Table S60.  Gene #41: 'amp_18p11.31' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 41(18P11.31) MUTATED 89 67.7 (9.1)
AMP PEAK 41(18P11.31) WILD-TYPE 415 63.0 (11.5)

Figure S60.  Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #2: 'AGE'

'amp_18p11.31' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S61.  Gene #41: 'amp_18p11.31' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 41(18P11.31) MUTATED 27 6 56
AMP PEAK 41(18P11.31) WILD-TYPE 353 15 48

Figure S61.  Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_18q11.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S62.  Gene #42: 'amp_18q11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 42(18Q11.2) MUTATED 18 4 42
AMP PEAK 42(18Q11.2) WILD-TYPE 362 17 62

Figure S62.  Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_19p13.2' versus 'AGE'

P value = 4.21e-10 (Wilcoxon-test), Q value = 2.9e-07

Table S63.  Gene #43: 'amp_19p13.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 43(19P13.2) MUTATED 90 70.2 (8.6)
AMP PEAK 43(19P13.2) WILD-TYPE 414 62.5 (11.2)

Figure S63.  Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #2: 'AGE'

'amp_19p13.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S64.  Gene #43: 'amp_19p13.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 43(19P13.2) MUTATED 23 7 60
AMP PEAK 43(19P13.2) WILD-TYPE 357 14 44

Figure S64.  Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_19q12' versus 'Time to Death'

P value = 0.00023 (logrank test), Q value = 0.13

Table S65.  Gene #44: 'amp_19q12' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
AMP PEAK 44(19Q12) MUTATED 106 22 0.0 - 125.4 (18.1)
AMP PEAK 44(19Q12) WILD-TYPE 397 38 0.1 - 191.8 (23.5)

Figure S65.  Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #1: 'Time to Death'

'amp_19q12' versus 'AGE'

P value = 3e-08 (Wilcoxon-test), Q value = 2.1e-05

Table S66.  Gene #44: 'amp_19q12' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 44(19Q12) MUTATED 106 68.8 (8.6)
AMP PEAK 44(19Q12) WILD-TYPE 398 62.5 (11.5)

Figure S66.  Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #2: 'AGE'

'amp_19q12' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S67.  Gene #44: 'amp_19q12' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 44(19Q12) MUTATED 25 10 71
AMP PEAK 44(19Q12) WILD-TYPE 355 11 33

Figure S67.  Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_19q12' versus 'RACE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S68.  Gene #44: 'amp_19q12' versus Clinical Feature #6: 'RACE'

nPatients AMERICAN INDIAN OR ALASKA NATIVE ASIAN BLACK OR AFRICAN AMERICAN NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER WHITE
ALL 4 19 90 9 357
AMP PEAK 44(19Q12) MUTATED 1 2 38 3 57
AMP PEAK 44(19Q12) WILD-TYPE 3 17 52 6 300

Figure S68.  Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #6: 'RACE'

'amp_20p13' versus 'AGE'

P value = 5.13e-06 (Wilcoxon-test), Q value = 0.0035

Table S69.  Gene #45: 'amp_20p13' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 45(20P13) MUTATED 110 67.7 (11.0)
AMP PEAK 45(20P13) WILD-TYPE 394 62.8 (11.1)

Figure S69.  Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #2: 'AGE'

'amp_20p13' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S70.  Gene #45: 'amp_20p13' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 45(20P13) MUTATED 50 5 55
AMP PEAK 45(20P13) WILD-TYPE 330 16 49

Figure S70.  Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_20q11.21' versus 'AGE'

P value = 7.39e-08 (Wilcoxon-test), Q value = 5.1e-05

Table S71.  Gene #46: 'amp_20q11.21' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 46(20Q11.21) MUTATED 140 67.9 (9.8)
AMP PEAK 46(20Q11.21) WILD-TYPE 364 62.3 (11.3)

Figure S71.  Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #2: 'AGE'

'amp_20q11.21' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S72.  Gene #46: 'amp_20q11.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 46(20Q11.21) MUTATED 58 6 76
AMP PEAK 46(20Q11.21) WILD-TYPE 322 15 28

Figure S72.  Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_20q13.12' versus 'AGE'

P value = 3.13e-08 (Wilcoxon-test), Q value = 2.2e-05

Table S73.  Gene #47: 'amp_20q13.12' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 47(20Q13.12) MUTATED 140 68.1 (10.1)
AMP PEAK 47(20Q13.12) WILD-TYPE 364 62.2 (11.2)

Figure S73.  Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #2: 'AGE'

'amp_20q13.12' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S74.  Gene #47: 'amp_20q13.12' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 47(20Q13.12) MUTATED 60 7 73
AMP PEAK 47(20Q13.12) WILD-TYPE 320 14 31

Figure S74.  Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_20q13.33' versus 'AGE'

P value = 4.38e-08 (Wilcoxon-test), Q value = 3e-05

Table S75.  Gene #48: 'amp_20q13.33' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
AMP PEAK 48(20Q13.33) MUTATED 138 68.1 (10.2)
AMP PEAK 48(20Q13.33) WILD-TYPE 366 62.2 (11.2)

Figure S75.  Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #2: 'AGE'

'amp_20q13.33' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S76.  Gene #48: 'amp_20q13.33' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 48(20Q13.33) MUTATED 61 6 71
AMP PEAK 48(20Q13.33) WILD-TYPE 319 15 33

Figure S76.  Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'amp_22q12.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S77.  Gene #49: 'amp_22q12.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
AMP PEAK 49(22Q12.2) MUTATED 11 2 45
AMP PEAK 49(22Q12.2) WILD-TYPE 369 19 59

Figure S77.  Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_1p36.21' versus 'AGE'

P value = 9.94e-05 (Wilcoxon-test), Q value = 0.056

Table S78.  Gene #52: 'del_1p36.21' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 1(1P36.21) MUTATED 64 69.4 (10.5)
DEL PEAK 1(1P36.21) WILD-TYPE 440 63.0 (11.1)

Figure S78.  Get High-res Image Gene #52: 'del_1p36.21' versus Clinical Feature #2: 'AGE'

'del_1p36.21' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S79.  Gene #52: 'del_1p36.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 1(1P36.21) MUTATED 26 5 33
DEL PEAK 1(1P36.21) WILD-TYPE 354 16 71

Figure S79.  Get High-res Image Gene #52: 'del_1p36.21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_1p36.11' versus 'AGE'

P value = 4.73e-05 (Wilcoxon-test), Q value = 0.027

Table S80.  Gene #53: 'del_1p36.11' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 2(1P36.11) MUTATED 74 68.9 (9.6)
DEL PEAK 2(1P36.11) WILD-TYPE 430 63.0 (11.3)

Figure S80.  Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #2: 'AGE'

'del_1p36.11' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S81.  Gene #53: 'del_1p36.11' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 2(1P36.11) MUTATED 24 5 45
DEL PEAK 2(1P36.11) WILD-TYPE 356 16 59

Figure S81.  Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_2q22.1' versus 'Time to Death'

P value = 3.43e-09 (logrank test), Q value = 2.4e-06

Table S82.  Gene #55: 'del_2q22.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
DEL PEAK 4(2Q22.1) MUTATED 44 15 0.5 - 125.4 (11.3)
DEL PEAK 4(2Q22.1) WILD-TYPE 459 45 0.0 - 191.8 (23.9)

Figure S82.  Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #1: 'Time to Death'

'del_2q22.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S83.  Gene #55: 'del_2q22.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 4(2Q22.1) MUTATED 16 2 26
DEL PEAK 4(2Q22.1) WILD-TYPE 364 19 78

Figure S83.  Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_2q37.3' versus 'HISTOLOGICAL.TYPE'

P value = 0.00014 (Fisher's exact test), Q value = 0.079

Table S84.  Gene #56: 'del_2q37.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 5(2Q37.3) MUTATED 25 2 22
DEL PEAK 5(2Q37.3) WILD-TYPE 355 19 82

Figure S84.  Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_3p14.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S85.  Gene #57: 'del_3p14.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 6(3P14.2) MUTATED 23 6 40
DEL PEAK 6(3P14.2) WILD-TYPE 357 15 64

Figure S85.  Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_3q13.31' versus 'HISTOLOGICAL.TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.012

Table S86.  Gene #58: 'del_3q13.31' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 7(3Q13.31) MUTATED 17 3 20
DEL PEAK 7(3Q13.31) WILD-TYPE 363 18 84

Figure S86.  Get High-res Image Gene #58: 'del_3q13.31' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_4p16.3' versus 'AGE'

P value = 0.000385 (Wilcoxon-test), Q value = 0.21

Table S87.  Gene #59: 'del_4p16.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 8(4P16.3) MUTATED 81 67.9 (9.1)
DEL PEAK 8(4P16.3) WILD-TYPE 423 63.1 (11.4)

Figure S87.  Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #2: 'AGE'

'del_4p16.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S88.  Gene #59: 'del_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 8(4P16.3) MUTATED 28 5 48
DEL PEAK 8(4P16.3) WILD-TYPE 352 16 56

Figure S88.  Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_4p15.2' versus 'AGE'

P value = 0.000164 (Wilcoxon-test), Q value = 0.092

Table S89.  Gene #60: 'del_4p15.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 9(4P15.2) MUTATED 83 68.1 (9.2)
DEL PEAK 9(4P15.2) WILD-TYPE 421 63.0 (11.4)

Figure S89.  Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #2: 'AGE'

'del_4p15.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S90.  Gene #60: 'del_4p15.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 9(4P15.2) MUTATED 29 5 49
DEL PEAK 9(4P15.2) WILD-TYPE 351 16 55

Figure S90.  Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_4q22.1' versus 'AGE'

P value = 4.13e-06 (Wilcoxon-test), Q value = 0.0028

Table S91.  Gene #61: 'del_4q22.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 10(4Q22.1) MUTATED 94 68.5 (9.1)
DEL PEAK 10(4Q22.1) WILD-TYPE 410 62.8 (11.4)

Figure S91.  Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #2: 'AGE'

'del_4q22.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S92.  Gene #61: 'del_4q22.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 10(4Q22.1) MUTATED 28 6 60
DEL PEAK 10(4Q22.1) WILD-TYPE 352 15 44

Figure S92.  Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_4q34.3' versus 'AGE'

P value = 5.71e-07 (Wilcoxon-test), Q value = 0.00039

Table S93.  Gene #62: 'del_4q34.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 11(4Q34.3) MUTATED 120 68.0 (9.9)
DEL PEAK 11(4Q34.3) WILD-TYPE 384 62.5 (11.3)

Figure S93.  Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #2: 'AGE'

'del_4q34.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S94.  Gene #62: 'del_4q34.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 11(4Q34.3) MUTATED 41 8 71
DEL PEAK 11(4Q34.3) WILD-TYPE 339 13 33

Figure S94.  Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_5q12.1' versus 'AGE'

P value = 1.22e-05 (Wilcoxon-test), Q value = 0.0071

Table S95.  Gene #63: 'del_5q12.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 12(5Q12.1) MUTATED 101 67.7 (9.8)
DEL PEAK 12(5Q12.1) WILD-TYPE 403 62.9 (11.4)

Figure S95.  Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #2: 'AGE'

'del_5q12.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S96.  Gene #63: 'del_5q12.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 12(5Q12.1) MUTATED 32 4 65
DEL PEAK 12(5Q12.1) WILD-TYPE 348 17 39

Figure S96.  Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_6q26' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S97.  Gene #64: 'del_6q26' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 13(6Q26) MUTATED 12 3 28
DEL PEAK 13(6Q26) WILD-TYPE 368 18 76

Figure S97.  Get High-res Image Gene #64: 'del_6q26' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_7p22.3' versus 'AGE'

P value = 0.000132 (Wilcoxon-test), Q value = 0.074

Table S98.  Gene #65: 'del_7p22.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 14(7P22.3) MUTATED 66 68.5 (10.1)
DEL PEAK 14(7P22.3) WILD-TYPE 438 63.1 (11.2)

Figure S98.  Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #2: 'AGE'

'del_7p22.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S99.  Gene #65: 'del_7p22.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 14(7P22.3) MUTATED 21 5 41
DEL PEAK 14(7P22.3) WILD-TYPE 359 16 63

Figure S99.  Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_7q11.22' versus 'AGE'

P value = 3.18e-05 (Wilcoxon-test), Q value = 0.018

Table S100.  Gene #66: 'del_7q11.22' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 15(7Q11.22) MUTATED 39 70.7 (9.8)
DEL PEAK 15(7Q11.22) WILD-TYPE 465 63.3 (11.2)

Figure S100.  Get High-res Image Gene #66: 'del_7q11.22' versus Clinical Feature #2: 'AGE'

'del_7q11.22' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S101.  Gene #66: 'del_7q11.22' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 15(7Q11.22) MUTATED 13 2 24
DEL PEAK 15(7Q11.22) WILD-TYPE 367 19 80

Figure S101.  Get High-res Image Gene #66: 'del_7q11.22' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_7q31.1' versus 'AGE'

P value = 4.75e-05 (Wilcoxon-test), Q value = 0.027

Table S102.  Gene #67: 'del_7q31.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 16(7Q31.1) MUTATED 52 69.4 (7.9)
DEL PEAK 16(7Q31.1) WILD-TYPE 452 63.2 (11.4)

Figure S102.  Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #2: 'AGE'

'del_7q31.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S103.  Gene #67: 'del_7q31.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 16(7Q31.1) MUTATED 9 3 40
DEL PEAK 16(7Q31.1) WILD-TYPE 371 18 64

Figure S103.  Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_7q36.1' versus 'AGE'

P value = 2.17e-07 (Wilcoxon-test), Q value = 0.00015

Table S104.  Gene #68: 'del_7q36.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 17(7Q36.1) MUTATED 61 70.6 (8.6)
DEL PEAK 17(7Q36.1) WILD-TYPE 443 62.9 (11.2)

Figure S104.  Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #2: 'AGE'

'del_7q36.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S105.  Gene #68: 'del_7q36.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 17(7Q36.1) MUTATED 12 4 45
DEL PEAK 17(7Q36.1) WILD-TYPE 368 17 59

Figure S105.  Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_8p23.2' versus 'AGE'

P value = 3.52e-05 (Wilcoxon-test), Q value = 0.02

Table S106.  Gene #69: 'del_8p23.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 18(8P23.2) MUTATED 105 67.4 (9.3)
DEL PEAK 18(8P23.2) WILD-TYPE 399 62.9 (11.5)

Figure S106.  Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #2: 'AGE'

'del_8p23.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S107.  Gene #69: 'del_8p23.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 18(8P23.2) MUTATED 31 5 70
DEL PEAK 18(8P23.2) WILD-TYPE 349 16 34

Figure S107.  Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_8p21.2' versus 'AGE'

P value = 4.25e-06 (Wilcoxon-test), Q value = 0.0029

Table S108.  Gene #70: 'del_8p21.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 19(8P21.2) MUTATED 104 68.0 (9.2)
DEL PEAK 19(8P21.2) WILD-TYPE 400 62.8 (11.5)

Figure S108.  Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #2: 'AGE'

'del_8p21.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S109.  Gene #70: 'del_8p21.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 19(8P21.2) MUTATED 23 6 75
DEL PEAK 19(8P21.2) WILD-TYPE 357 15 29

Figure S109.  Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_9p23' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S110.  Gene #71: 'del_9p23' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 20(9P23) MUTATED 27 4 39
DEL PEAK 20(9P23) WILD-TYPE 353 17 65

Figure S110.  Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_9q21.2' versus 'AGE'

P value = 5.62e-10 (Wilcoxon-test), Q value = 3.9e-07

Table S111.  Gene #72: 'del_9q21.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 21(9Q21.2) MUTATED 117 69.2 (9.0)
DEL PEAK 21(9Q21.2) WILD-TYPE 387 62.2 (11.3)

Figure S111.  Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #2: 'AGE'

'del_9q21.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S112.  Gene #72: 'del_9q21.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 21(9Q21.2) MUTATED 46 10 61
DEL PEAK 21(9Q21.2) WILD-TYPE 334 11 43

Figure S112.  Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_9q34.2' versus 'AGE'

P value = 3.56e-08 (Wilcoxon-test), Q value = 2.5e-05

Table S113.  Gene #73: 'del_9q34.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 22(9Q34.2) MUTATED 119 68.5 (8.6)
DEL PEAK 22(9Q34.2) WILD-TYPE 385 62.4 (11.5)

Figure S113.  Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #2: 'AGE'

'del_9q34.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S114.  Gene #73: 'del_9q34.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 22(9Q34.2) MUTATED 49 10 60
DEL PEAK 22(9Q34.2) WILD-TYPE 331 11 44

Figure S114.  Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_10q23.31' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S115.  Gene #74: 'del_10q23.31' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 23(10Q23.31) MUTATED 29 5 34
DEL PEAK 23(10Q23.31) WILD-TYPE 351 16 70

Figure S115.  Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_11p15.5' versus 'AGE'

P value = 9.43e-06 (Wilcoxon-test), Q value = 0.0063

Table S116.  Gene #75: 'del_11p15.5' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 24(11P15.5) MUTATED 94 68.2 (9.1)
DEL PEAK 24(11P15.5) WILD-TYPE 410 62.8 (11.4)

Figure S116.  Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #2: 'AGE'

'del_11p15.5' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S117.  Gene #75: 'del_11p15.5' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 24(11P15.5) MUTATED 32 5 57
DEL PEAK 24(11P15.5) WILD-TYPE 348 16 47

Figure S117.  Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_11q14.1' versus 'AGE'

P value = 0.000357 (Wilcoxon-test), Q value = 0.19

Table S118.  Gene #76: 'del_11q14.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 25(11Q14.1) MUTATED 64 68.6 (9.1)
DEL PEAK 25(11Q14.1) WILD-TYPE 440 63.1 (11.3)

Figure S118.  Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #2: 'AGE'

'del_11q14.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S119.  Gene #76: 'del_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 25(11Q14.1) MUTATED 20 6 38
DEL PEAK 25(11Q14.1) WILD-TYPE 360 15 66

Figure S119.  Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_11q25' versus 'AGE'

P value = 0.000283 (Wilcoxon-test), Q value = 0.16

Table S120.  Gene #77: 'del_11q25' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 26(11Q25) MUTATED 86 67.5 (10.0)
DEL PEAK 26(11Q25) WILD-TYPE 418 63.1 (11.3)

Figure S120.  Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #2: 'AGE'

'del_11q25' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S121.  Gene #77: 'del_11q25' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 26(11Q25) MUTATED 31 6 49
DEL PEAK 26(11Q25) WILD-TYPE 349 15 55

Figure S121.  Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_12q23.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S122.  Gene #78: 'del_12q23.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 27(12Q23.1) MUTATED 11 3 32
DEL PEAK 27(12Q23.1) WILD-TYPE 369 18 72

Figure S122.  Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_12q24.33' versus 'AGE'

P value = 3.82e-05 (Wilcoxon-test), Q value = 0.022

Table S123.  Gene #79: 'del_12q24.33' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 28(12Q24.33) MUTATED 56 69.4 (9.1)
DEL PEAK 28(12Q24.33) WILD-TYPE 448 63.1 (11.3)

Figure S123.  Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #2: 'AGE'

'del_12q24.33' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S124.  Gene #79: 'del_12q24.33' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 28(12Q24.33) MUTATED 16 2 38
DEL PEAK 28(12Q24.33) WILD-TYPE 364 19 66

Figure S124.  Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_13q11' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S125.  Gene #80: 'del_13q11' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 29(13Q11) MUTATED 36 5 45
DEL PEAK 29(13Q11) WILD-TYPE 344 16 59

Figure S125.  Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_13q14.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S126.  Gene #81: 'del_13q14.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 30(13Q14.2) MUTATED 48 6 39
DEL PEAK 30(13Q14.2) WILD-TYPE 332 15 65

Figure S126.  Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_14q13.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S127.  Gene #82: 'del_14q13.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 31(14Q13.1) MUTATED 24 5 38
DEL PEAK 31(14Q13.1) WILD-TYPE 356 16 66

Figure S127.  Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_15q15.1' versus 'AGE'

P value = 4.08e-08 (Wilcoxon-test), Q value = 2.8e-05

Table S128.  Gene #83: 'del_15q15.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 32(15Q15.1) MUTATED 128 68.3 (9.7)
DEL PEAK 32(15Q15.1) WILD-TYPE 376 62.3 (11.3)

Figure S128.  Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #2: 'AGE'

'del_15q15.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S129.  Gene #83: 'del_15q15.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 32(15Q15.1) MUTATED 49 9 70
DEL PEAK 32(15Q15.1) WILD-TYPE 331 12 34

Figure S129.  Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_15q23' versus 'AGE'

P value = 1.23e-05 (Wilcoxon-test), Q value = 0.0071

Table S130.  Gene #84: 'del_15q23' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 33(15Q23) MUTATED 107 67.6 (9.5)
DEL PEAK 33(15Q23) WILD-TYPE 397 62.8 (11.4)

Figure S130.  Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #2: 'AGE'

'del_15q23' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S131.  Gene #84: 'del_15q23' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 33(15Q23) MUTATED 37 7 63
DEL PEAK 33(15Q23) WILD-TYPE 343 14 41

Figure S131.  Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_16p13.3' versus 'AGE'

P value = 1.33e-06 (Wilcoxon-test), Q value = 9e-04

Table S132.  Gene #85: 'del_16p13.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 34(16P13.3) MUTATED 83 69.0 (8.6)
DEL PEAK 34(16P13.3) WILD-TYPE 421 62.8 (11.4)

Figure S132.  Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #2: 'AGE'

'del_16p13.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S133.  Gene #85: 'del_16p13.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 34(16P13.3) MUTATED 24 5 54
DEL PEAK 34(16P13.3) WILD-TYPE 356 16 50

Figure S133.  Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_16q21' versus 'AGE'

P value = 2.59e-08 (Wilcoxon-test), Q value = 1.8e-05

Table S134.  Gene #86: 'del_16q21' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 35(16Q21) MUTATED 141 68.0 (9.2)
DEL PEAK 35(16Q21) WILD-TYPE 363 62.2 (11.5)

Figure S134.  Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #2: 'AGE'

'del_16q21' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S135.  Gene #86: 'del_16q21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 35(16Q21) MUTATED 59 8 74
DEL PEAK 35(16Q21) WILD-TYPE 321 13 30

Figure S135.  Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_16q22.3' versus 'AGE'

P value = 1.78e-08 (Wilcoxon-test), Q value = 1.2e-05

Table S136.  Gene #87: 'del_16q22.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 36(16Q22.3) MUTATED 144 67.9 (9.0)
DEL PEAK 36(16Q22.3) WILD-TYPE 360 62.2 (11.6)

Figure S136.  Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #2: 'AGE'

'del_16q22.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S137.  Gene #87: 'del_16q22.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 36(16Q22.3) MUTATED 63 8 73
DEL PEAK 36(16Q22.3) WILD-TYPE 317 13 31

Figure S137.  Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_16q23.1' versus 'AGE'

P value = 2.47e-08 (Wilcoxon-test), Q value = 1.7e-05

Table S138.  Gene #88: 'del_16q23.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 37(16Q23.1) MUTATED 152 67.7 (9.4)
DEL PEAK 37(16Q23.1) WILD-TYPE 352 62.2 (11.5)

Figure S138.  Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #2: 'AGE'

'del_16q23.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S139.  Gene #88: 'del_16q23.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 37(16Q23.1) MUTATED 65 7 80
DEL PEAK 37(16Q23.1) WILD-TYPE 315 14 24

Figure S139.  Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_17p13.3' versus 'AGE'

P value = 0.000294 (Wilcoxon-test), Q value = 0.16

Table S140.  Gene #89: 'del_17p13.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 38(17P13.3) MUTATED 110 66.9 (9.1)
DEL PEAK 38(17P13.3) WILD-TYPE 394 63.0 (11.6)

Figure S140.  Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #2: 'AGE'

'del_17p13.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S141.  Gene #89: 'del_17p13.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 38(17P13.3) MUTATED 42 9 59
DEL PEAK 38(17P13.3) WILD-TYPE 338 12 45

Figure S141.  Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_17p11.2' versus 'AGE'

P value = 5.37e-06 (Wilcoxon-test), Q value = 0.0036

Table S142.  Gene #90: 'del_17p11.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 39(17P11.2) MUTATED 115 67.7 (9.4)
DEL PEAK 39(17P11.2) WILD-TYPE 389 62.7 (11.5)

Figure S142.  Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #2: 'AGE'

'del_17p11.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S143.  Gene #90: 'del_17p11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 39(17P11.2) MUTATED 41 8 66
DEL PEAK 39(17P11.2) WILD-TYPE 339 13 38

Figure S143.  Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_17q11.2' versus 'AGE'

P value = 1.13e-06 (Wilcoxon-test), Q value = 0.00077

Table S144.  Gene #91: 'del_17q11.2' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 40(17Q11.2) MUTATED 95 68.2 (9.4)
DEL PEAK 40(17Q11.2) WILD-TYPE 409 62.8 (11.4)

Figure S144.  Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #2: 'AGE'

'del_17q11.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S145.  Gene #91: 'del_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 40(17Q11.2) MUTATED 42 5 48
DEL PEAK 40(17Q11.2) WILD-TYPE 338 16 56

Figure S145.  Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_17q21.31' versus 'AGE'

P value = 1.77e-05 (Wilcoxon-test), Q value = 0.01

Table S146.  Gene #92: 'del_17q21.31' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 41(17Q21.31) MUTATED 100 67.8 (9.9)
DEL PEAK 41(17Q21.31) WILD-TYPE 404 62.9 (11.3)

Figure S146.  Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #2: 'AGE'

'del_17q21.31' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S147.  Gene #92: 'del_17q21.31' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 41(17Q21.31) MUTATED 41 5 54
DEL PEAK 41(17Q21.31) WILD-TYPE 339 16 50

Figure S147.  Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_18q21.2' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S148.  Gene #93: 'del_18q21.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 42(18Q21.2) MUTATED 35 6 41
DEL PEAK 42(18Q21.2) WILD-TYPE 345 15 63

Figure S148.  Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_18q23' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S149.  Gene #94: 'del_18q23' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 43(18Q23) MUTATED 34 6 47
DEL PEAK 43(18Q23) WILD-TYPE 346 15 57

Figure S149.  Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_19p13.3' versus 'Time to Death'

P value = 1.45e-05 (logrank test), Q value = 0.0084

Table S150.  Gene #95: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
DEL PEAK 44(19P13.3) MUTATED 140 30 0.0 - 125.4 (19.7)
DEL PEAK 44(19P13.3) WILD-TYPE 363 30 0.1 - 191.8 (23.5)

Figure S150.  Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

'del_19p13.3' versus 'AGE'

P value = 2.02e-10 (Wilcoxon-test), Q value = 1.4e-07

Table S151.  Gene #95: 'del_19p13.3' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 44(19P13.3) MUTATED 141 68.5 (8.7)
DEL PEAK 44(19P13.3) WILD-TYPE 363 62.0 (11.6)

Figure S151.  Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #2: 'AGE'

'del_19p13.3' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S152.  Gene #95: 'del_19p13.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 44(19P13.3) MUTATED 41 8 92
DEL PEAK 44(19P13.3) WILD-TYPE 339 13 12

Figure S152.  Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_19p12' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S153.  Gene #96: 'del_19p12' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 45(19P12) MUTATED 19 5 28
DEL PEAK 45(19P12) WILD-TYPE 361 16 76

Figure S153.  Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_19q13.43' versus 'Time to Death'

P value = 0.00029 (logrank test), Q value = 0.16

Table S154.  Gene #97: 'del_19q13.43' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
DEL PEAK 46(19Q13.43) MUTATED 57 15 0.0 - 125.4 (20.0)
DEL PEAK 46(19Q13.43) WILD-TYPE 446 45 0.1 - 191.8 (23.1)

Figure S154.  Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #1: 'Time to Death'

'del_19q13.43' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S155.  Gene #97: 'del_19q13.43' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 46(19Q13.43) MUTATED 15 4 39
DEL PEAK 46(19Q13.43) WILD-TYPE 365 17 65

Figure S155.  Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_20p12.1' versus 'Time to Death'

P value = 1.98e-05 (logrank test), Q value = 0.011

Table S156.  Gene #98: 'del_20p12.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
DEL PEAK 47(20P12.1) MUTATED 31 12 0.1 - 149.6 (20.0)
DEL PEAK 47(20P12.1) WILD-TYPE 472 48 0.0 - 191.8 (23.0)

Figure S156.  Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #1: 'Time to Death'

'del_22q13.32' versus 'AGE'

P value = 4.3e-08 (Wilcoxon-test), Q value = 3e-05

Table S157.  Gene #99: 'del_22q13.32' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 48(22Q13.32) MUTATED 129 68.5 (9.6)
DEL PEAK 48(22Q13.32) WILD-TYPE 375 62.2 (11.3)

Figure S157.  Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #2: 'AGE'

'del_22q13.32' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S158.  Gene #99: 'del_22q13.32' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 48(22Q13.32) MUTATED 51 10 68
DEL PEAK 48(22Q13.32) WILD-TYPE 329 11 36

Figure S158.  Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

'del_xp21.1' versus 'Time to Death'

P value = 0.000365 (logrank test), Q value = 0.2

Table S159.  Gene #100: 'del_xp21.1' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 503 60 0.0 - 191.8 (22.8)
DEL PEAK 49(XP21.1) MUTATED 77 18 0.0 - 113.4 (17.9)
DEL PEAK 49(XP21.1) WILD-TYPE 426 42 0.1 - 191.8 (23.3)

Figure S159.  Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #1: 'Time to Death'

'del_xp21.1' versus 'AGE'

P value = 0.000263 (Wilcoxon-test), Q value = 0.14

Table S160.  Gene #100: 'del_xp21.1' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 504 63.8 (11.2)
DEL PEAK 49(XP21.1) MUTATED 77 67.9 (9.4)
DEL PEAK 49(XP21.1) WILD-TYPE 427 63.1 (11.4)

Figure S160.  Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #2: 'AGE'

'del_xp21.1' versus 'HISTOLOGICAL.TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 0.0067

Table S161.  Gene #100: 'del_xp21.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 380 21 104
DEL PEAK 49(XP21.1) MUTATED 28 3 46
DEL PEAK 49(XP21.1) WILD-TYPE 352 18 58

Figure S161.  Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #3: 'HISTOLOGICAL.TYPE'

Methods & Data
Input
  • Copy number data file = transformed.cor.cli.txt

  • Clinical data file = UCEC-TP.merged_data.txt

  • Number of patients = 505

  • Number of significantly focal cnvs = 100

  • Number of selected clinical features = 7

  • Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[3] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)